Rule/Regulation Violated:
R9-10-817.B.3.a-c. Medication Services<br> B. If an assisted living facility provides medication administration, a manager shall ensure that: <br>3. A medication administered to a resident: <br>a. Is administered by an individual under the direction of a medical practitioner, <br>b. Is administered in compliance with a medication order, and <br>c. Is documented in the resident’s medical record.
Evidence/Findings:
<p>Based on record review, observation, and interview, the manager failed to ensure that a medication administered to a resident was administered in compliance with a medication order and documented in the resident's medical record, for three of four residents sampled. The deficient practice posed a risk if the resident experienced a change in condition due to improper administration of medication.</p><p><br></p><p><br></p><p>Findings include: </p><p><br></p><p><br></p><p>1. A review of R2's medical record revealed a medication order, dated July 14, 2025, for Aspirin 81 milligrams (mg), 1 tablet by mouth (po) daily (qd).</p><p><br></p><p><br></p><p>2. A review of R2's medication administration record (MAR) for July 2025 revealed R2 was administered Aspirin 81 mg on July 16, 2025, and July 19, 2025.</p><p><br></p><p><br></p><p>3. While on-site for the compliance and complaint inspection, the Compliance Officers did not observe Aspirin 81 mg stored at the facility for administration to R2.</p><p><br></p><p><br></p><p>4. In an interview, E6 reported R2's family will provide Aspirin 81 mg for administration to R2. However, at the time of inspection, the medication had not been provided.</p><p><br></p><p><br></p><p>5. A review of R3's medical record revealed a medication order, dated November 21, 2024, for Famotidine 20 mg, 1 tablet po qd.</p><p><br></p><p><br></p><p>6. A review of R3's MAR for July 2025 revealed R2 was not administered Famotidine 20 mg on the following dates:</p><ul><li>July 1, 2025;</li><li>July 8, 2025;</li><li>July 9, 2025;</li><li>July 10, 2025;</li><li>July 13, 2025;</li><li>July 14, 2025;</li><li>July 15, 2025; and</li><li>July 22, 2025.</li></ul><p>However, nursing notes revealed the medication was not administered due to the medication not being available for administration.</p><p><br></p><p><br></p><p>7. While on-site for the compliance and complaint inspection, the Compliance Officers observed two bubble packs of Acid Reducer 20 mg stored for administration to R3.</p><p><br></p><p><br></p><p>8. In an interview, E6 reported the medication observed for administration to R3 was the generic for Famotidine 20 mg.</p><p><br></p><p><br></p><p>9. A review of R4's medical record revealed medication orders for the following medications:</p><ul><li>Risperidone 0.25 mg, 1 tablet po twice a day (bid);</li><li>Valproic Acid 250 mg, 5 milliliters (mL) po bid; and</li><li>Atorvastatin 10 mg, 1 tablet po at bedtime (qhs).</li></ul><p><br></p><p>10. A review of R4's MAR for July 2025 did not include documentation of administration of the aforementioned medications to R4 on July 6, 2025 during the PM shift.</p><p><br></p><p><br></p><p>11. In an interview, E6 reported R4 was currently at the facility on July 6, 2025.</p><p><br></p><p><br></p><p>12. In an interview, the finding was reviewed with E2, and no additional information was provided.</p><p><br></p><p><br></p><p>13. This is a repeat deficiency from the inspections conducted on July 2, 2024 and October 31, 2024. </p>
Temporary Solution:
Shea Rambow, Manager and Director of Resident Services, audited the resident medication orders (R2-4) to ensure the correct medications are being administered and documented.
Permanent Solution:
The community has a new electronic medication administration record (eMAR) software implemented in early 2025, will help with eliminating errors going forward. Also, the Director of Resident Services will now check the eMAR system at least every other day to check for any errors or concerns.
Summary:
No deficiencies were found during the on-site investigation of complaint 00137841 conducted on August 4, 2025.